The First Conference of Predictive Oncology:
Translating Emerging Molecular Data into Clinical Practice
לפניכם סיקור הכנס שהתקיים ב-21/12/2012
הסיקור בחסות חברת טבע
Genomic and Predictive studies - initial cases
Hovav Nechushtan M.D Ph.D.
Sharett Institute of Oncology, Hadassah Hebrew University Hospital
Novel crizotinib-sensitive ALK rearrangement in a patient with metastatic NSCLC
Nir Peled MD PhD FCCP
Head, Thoracic Cancer Research and Detection Center, Sheba Medical Center
NGS reveals acquired resistance to hormonal therapy in breast cancer patient
Noa Efrat Ben-Baruch, M.D.
Head of Department of Oncology, Kaplan Medical Center
Tailored treatment in CRC and GI cancer
Alexander Beny, MD.
Head, Gastrointestinal cancer service, Rambam Medical Center, Haifa
The predictive role of ERCC1 status in Oxaliplatin based neoadjuvant therapy for metastatic colorectal cancer (mCRC) to the liver
Ravit Geva, M.D.
Head, Gastrointestinal malignancies Service Head, Research Unit, Division of Oncology, Tel-Aviv Sourasky Medical Center
Molecular Profiling – Selected Therapy for the Treatment of Patients with Advanced Pancreaticobiliary CancerRon Epelbaum, M.D.
Director, Ambulatory Care Unit, Oncology Division, Rambam Health Care Campus, Haifa
Biological tailored driven treatment for metastatic ACC
Aron Popovtzer, M.D.
Head & Neck Cancer Unit, Davidoff Cancer Center, Rabin Medical center, Sackler Faculty of Medicine, Tel Aviv University
בהפקת אלדן הפקות
